Senti Biosciences Holdings, Inc. Common Stock (SNTI) is a publicly traded Healthcare sector company. As of July 15, 2026, SNTI trades at $0.89 with a market cap of $29.90M and a P/E ratio of -0.36. SNTI moved -7.91% today. Year to date, SNTI is -6.97%; over the trailing twelve months it is -50.89%. Its 52-week range spans $0.77 to $16.94. Analyst consensus is buy with an average price target of $12.00. Rallies surfaces SNTI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover SNTI: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $12.00.
| Metric | Value |
|---|---|
| Price | $0.89 |
| Market Cap | $29.90M |
| P/E Ratio | -0.36 |
| EPS | $-2.73 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.94 |
| 52-Week Low | $0.77 |
| Volume | 603.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $22.00K |
| Net Income | $-61.44M |
| Gross Margin | 0.00% |
2 analysts cover SNTI: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $12.00.